Rebholz et al. Am J Otolaryngol. 2021


Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence. Rebholz H, Pfaffeneder-Mantaid F, Knoll W, Hassel AW, Frank W, Kleber C. Am J Otolaryngol. 2021. Volume 42, Issue 5, 103014, ISSN 0196-0709. Download from HAL-INSERM


Our study of 70 SARS-CoV-2 antibody-positive and 348 control participants corroborates the finding that smell dysfunction is long-lasting (at least 4 months) or possibly permanent for a subset of mild or asymptomatic COVID-19 cases and that certain odors are particularly affected.


This knowledge could be exploited in cost-effective and fast specific smell tests the ENT clinic to monitor the recovery of olfactory function after SARS-CoV-2 infection.

This part of the website could either be in French or English, depending on the sources of the actualities.


 03 June 2022
Programming neural cells for disease modelling and therapy development
 06 May 2022
Phenomenology and pathophysiology of antipsychotic-induced compulsive behaviour
 01 April 2022
Medial Septum cholinergic inputs to CA2: a new role in social novelty discrimination
 04 March 2022
Molecular Dissection of Selective Neuronal Vulnerability in Alzheimer's Disease
 04 February 2022
Quantitative analysis and modelling of dendrite growth
 07 January 2022
Neurobiology of social and non social decision-making processes in mouse models
 21 December 2021 31 December 2021
Psychiatry and Neuroscience Seminar Series 2021
 03 December 2021
Deconstructing the role of dopamine signaling in defensive behaviors
 05 November 2021
Molecular mechanisms of synaptic development: insights from a human-specific gene
 01 October 2021
Implementing motor learning in stroke neurorehabilitation
 03 September 2021
Neurodegenerative diseases in the age of genetic engineering
 02 July 2021
From neuro-development to pediatric cancers: physiological and pathological contributions of axon guidance gene pathways
 04 June 2021
Sexual signaling in wild house mice
 07 May 2021
The axonal cytoskeleton at the nanoscale
 22 April 2021
Dabertrand et al. Proc Natl Acad Sci U S A. 2021
 22 April 2021
Duriez et al.  Eur Eat Disord Rev. 2021 Apr 14;. doi: 10.1002/erv.2829. [Epub ahead of print] PubMed PMID: 33851482
 20 April 2021
Rebholz et al. Am J Otolaryngol. 2021
 12 April 2021
Une équipe et quatre projets contre les AVC
 05 March 2021
Feeding behavior in preclinical models of obesity
 18 February 2021
In Memoriam Dr Deborah L. Levy